Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Growth hormone secretion stimulants claimed by Merck & Co.

Nov. 1, 1996

Pulmonary-delivered insulin advances through clinical trials

Nov. 1, 1996

Lilly reports long-acting, soluble insulin analogues

Nov. 1, 1996

Hypoglycemic agents disclosed by Yamanouchi

Nov. 1, 1996

Sheffield Medical Technologies and Alpha Therapeutic enter into option agreement

Nov. 1, 1996

Oncogene awarded drug discovery grant

Nov. 1, 1996

Lilly and Neurocrine collaborate in the areas of obesity and Alzheimer's disease

Nov. 1, 1996

Antiobesity proteins described by Lilly

Nov. 1, 1996

CRADA opportunity for the treatment of atherosclerosis and LCAT deficiency

Nov. 1, 1996

Mitsubishi to copromote OrthoLogic 1000 in Japan

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...